- Home
- XENE vs MQ Comparison
XENE vs MQ Comparison
Compare XENE & MQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- MQ
- Stock Information
- Founded
- XENE 1996
- MQ 2010
- Country
- XENE Canada
- MQ United States
- Employees
- XENE N/A
- MQ N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- MQ Computer Software: Prepackaged Software
- Sector
- XENE Health Care
- MQ Technology
- Exchange
- XENE Nasdaq
- MQ Nasdaq
- Market Cap
- XENE 2.4B
- MQ 2.9B
- IPO Year
- XENE 2014
- MQ 2021
- Fundamental
- Price
- XENE $39.21
- MQ $6.15
- Analyst Decision
- XENE Strong Buy
- MQ Hold
- Analyst Count
- XENE 11
- MQ 13
- Target Price
- XENE $52.73
- MQ $5.98
- AVG Volume (30 Days)
- XENE 833.8K
- MQ 4.0M
- Earning Date
- XENE 08-11-2025
- MQ 11-03-2025
- Dividend Yield
- XENE N/A
- MQ N/A
- EPS Growth
- XENE N/A
- MQ N/A
- EPS
- XENE N/A
- MQ N/A
- Revenue
- XENE $7,500,000.00
- MQ $553,223,000.00
- Revenue This Year
- XENE N/A
- MQ $21.16
- Revenue Next Year
- XENE $256.34
- MQ $21.56
- P/E Ratio
- XENE N/A
- MQ N/A
- Revenue Growth
- XENE N/A
- MQ 17.47
- 52 Week Low
- XENE $26.74
- MQ $3.37
- 52 Week High
- XENE $46.00
- MQ $7.04
- Technical
- Relative Strength Index (RSI)
- XENE 67.80
- MQ 51.47
- Support Level
- XENE $38.13
- MQ $5.98
- Resistance Level
- XENE $39.84
- MQ $6.46
- Average True Range (ATR)
- XENE 0.99
- MQ 0.15
- MACD
- XENE -0.09
- MQ -0.02
- Stochastic Oscillator
- XENE 77.70
- MQ 48.49
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About MQ Marqeta Inc.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.